Library / regulatory-reference
Cuba: Center for State Control of Medicines, Equipment and Medical Devices (CECMED)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Center for State Control of Medicines, Equipment and Medical Devices, known by its Spanish initials CECMED, is Cuba's regulatory authority for medicines, equipment and medical devices.
Cuba is unusual in the region for its substantial domestic biotechnology and pharmaceutical industry, which exports vaccines and biologics, so the center's oversight covers both an import market and an export-oriented national industry.
How products enter the market
Medicines require registration after evaluation of quality, safety and efficacy, and the center licenses and inspects manufacturers and distributors, including the domestic industry's production sites.
Post-market work includes quality control, safety monitoring and enforcement, with the center also providing product information to the public and professionals.
Regional and international role
The center is recognized regionally for its regulatory capacity, particularly its oversight of domestically developed biologics and vaccines, products that have been supplied across Latin America and beyond.
Its experience regulating a national biotech industry makes it a reference case for countries building both production capacity and regulatory strength in parallel.
Using this profile
The center publishes guidance and announcements in Spanish through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: CECMED illustrates the producer-state regulator: an authority whose hardest task is certifying an export-bound domestic biotech industry, not policing imports.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.